Company News

    RSS Feed

Naturally Splendid NATERA(tm) CBD Products Granted Approval in Japanese Market with First Step Japan

naturally-splendid-logo

October 16, 2017 | Naturally Splendid (TSXV:NSP) Enterprises Ltd. is pleased to announce the Japenese government has approved the Company’s Natera(R)CBD product line for distribution in Japan.

Naturally Splendid is very pleased to announce it has received approval from the Japanese regulatory bodies for two of its CBD capsule products; full spectrum hemp oil NATERA CBD  … Read More

Alumina Partners commits up to $6 mln to Naturally Splendid and Closes First Tranche Investment. Naturally Splendid also Extends Closing of Prosnack Acquisition.

naturally-splendid-logo

October 16, 2017 | Naturally Splendid (TSXV:NSP) Enterprises Ltd. is pleased to announce that on October 13, 2017, the Company entered into a non-binding agreement for a draw-down equity facility of up to $6,000,000 with Alumina Partners (Ontario) Ltd., a subsidiary of Alumina Partners LLC, a New York-based private equity firm. The agreement provides for  … Read More

Isodiol International Provides Corporate Update

isodiol-international-logo-small

October 13, 2017 | Isodiol International Inc. (CSE:ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, announces fiscal 2018 Q2 revenues of it’s wholly owned subsidiary ISO International LLC of, $4.07 million USD ($5.1 million CDN) compared to fiscal 2018  … Read More

Pieris Pharmaceuticals Appoints Ingmar Bruns, M.D., Ph.D., as Vice President of Clinical Development

October 12, 2017 | Pieris Pharmaceuticals (NASDAQ:PIRS) has announced that it has appointed Ingmar Bruns, M.D., Ph..D as vice president of clinical development.

As quoted in the press release:
 Dr. Bruns is an accomplished physician and brings to Pieris a wealth of oncology and hematology experience, a deep science background, and a strong clinical development acumen.

“We  … Read More